[PDF][PDF] Risk factors for postoperative incisional infection and anti-infective effects of jefuyin decoction in patients with colorectal cancer

J Tan, G Liu, Y Zhao, Z He, W Xiao, B Zhan, Y Zhou… - …, 2023 - farmaciajournal.com
To investigate the risk factors for postoperative incision infection in colorectal cancer surgery
patients, a study was conducted in which 240 patients were included. Study participants …

[HTML][HTML] Application value of laparoscopic surgery in elderly patients (≥ 75 years) with colorectal cancer and prognostic factors influencing 5-year overall survival

J Wang, Y Yang, W Li, B Yang, Z Tian… - American Journal of …, 2024 - ncbi.nlm.nih.gov
Objective: To investigate the application value of laparoscopic surgery in elderly patients (≥
75 years) with colorectal cancer, and to identify the prognostic factors influencing the long …

[PDF][PDF] ANALYSIS OF MAGNETIC RESONANCE PROBE-BASED OXALIPLATIN-RESVERATROL DRUG RELEASE-CONTROLLED NANOPARTICLE THERAPY FOR …

X BI, QI ZHANG, ZHE QI, L SONG - Farmacia, 2024 - farmaciajournal.com
The aim of this research was to investigate the effects of nanoparticles (NPs) of oxaliplatin
(OXE) and resveratrol (Res) on colorectal cancer (CRC) therapy. Carboxymethylchitosan …

[PDF][PDF] BEVACIZUMABIN AND FIRST-LINE CHEMOTHERAPY IN THE TREATMENT OF METASTATIC COLORECTAL CANCER: EVALUATION OF CLINICAL …

J LIANG, C XIANG, KE SUN - Farmacia, 2023 - farmaciajournal.com
The clinical effectiveness of bevacizumab in combination with FOLFIRI protocol first line
chemotherapy in the treatment of advanced colorectal cancer was evaluated. Eighty patients …

[PDF][PDF] INFLUENCE OF DUAL-RESPONSIVE OXALIPLATIN (L-OHP)-/NARINGIN (NAR) DRUG DELIVERY SYSTEM ON THE GROWTH OF COLORECTAL TUMORS …

W LI, C ZOU - farmaciajournal.com
The aim of this study was to develop a drug delivery system (DDS) for oxaliplatin (L-OHP)
and naringin (Nar) using pH-responsive and near-infrared (NIR) light-responsive …